[{"id":"lancet-haematology","kind":"journal","name":"The Lancet Haematology","route":"/journals/lancet-haematology/","commit":"0bdbdae6c6","date":"2026-09-09","author":"Jude Gomila","message":"Editing pass: every TL;DR and summary stands alone","file":"src/data/journals.ts","type":"changed","fields":[{"field":"tldr","before":"\"The Lancet's haematology journal: phase 2 and 3 trials in leukaemia, lymphoma and myeloma, transplant studies and global-access commentary on blood cancers.\"","after":"\"The Lancet Haematology is the Lancet's haematology journal, publishing phase 2 and 3 trials in leukaemia, lymphoma and myeloma, transplant studies and global-access commentary on blood cancers.\""},{"field":"summary","before":"\"Monthly since 2014. Publishes randomised and single-arm trials in blood cancers (CAR-T and bispecific follow-up, MDS and myelofibrosis studies), long-term outcomes, and Commissions on haematological care in low-incom...","after":"\"The Lancet Haematology has appeared monthly since 2014 and publishes randomised and single-arm trials in blood cancers (CAR-T and bispecific follow-up, MDS and myelofibrosis studies), long-term outcomes, and Commissi..."}]},{"id":"lancet-haematology","kind":"journal","name":"The Lancet Haematology","route":"/journals/lancet-haematology/","commit":"3d932e7abd","date":"2026-09-09","author":"Jude Gomila","message":"Journals: records for every venue cited by key papers","file":"src/data/journals.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"aka"},{"field":"matchNames"},{"field":"publisher"},{"field":"url"},{"field":"issn"},{"field":"scope"},{"field":"access"},{"field":"founded"},{"field":"impactFactor"},{"field":"tldr"},{"field":"summary"},{"field":"links"}]}]